Evidence map›Paper›PMID 28963220›Full record

ArticleGenome announcements2017

Draft Genome Sequences of

Pravin R Kaldhone, Bijay K Khajanchi, Jing Han, Rajesh Nayak, Steven C Ricke, Steven L Foley

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome announcements, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pravin R KaldhoneU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.
Bijay K KhajanchiU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.ORCID http://orcid.org/0000-0002-8616-6903
Jing HanU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA jing.han1@fda.hhs.gov steven.foley@fda.hhs.gov.
Rajesh NayakU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA.
Steven C RickeCenter for Food Safety, Department of Food Science, University of Arkansas, Fayetteville, Arkansas, USA.
Steven L FoleyU.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas, USA jing.han1@fda.hhs.gov steven.foley@fda.hhs.gov.

Funding

Study of the Cell-specific Inflammasome Responses During Defense Against Gram-negative BacteriaP20GM103625 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2012 to 2021
$21.5M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
NCATS NIH HHS UL1 TR000039NIGMS NIH HHS P20 GM103625
6 · The paper itself

Abstract

The draft genome sequences of eight

Identifiers

PMID28963220
PMCPMC5624766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.